Sorrento Therapeutics Inc. [NASDAQ:SRNE] is flashing a current price of $8.57. On Friday, the company’s daily low is at $9.93 as the high is reaching $11.08.
The price per sales of 74.52. The company is also booking -1.61 earnings per share.
The company has price per sales of 74.52. The company is also booking -1.61 earnings per share.
The Bears are coming
Holding a Market Cap of $2.65 billion, Sorrento Therapeutics Inc. has seen a trading range over the last year of $1.39-$19.39.
For the last five days, SRNE is down from its last closing price. The average shares trading hands each day is 40.91M, with average 10-day volume coming in at 43.32 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for SRNE. When we apply the Elder Force Index to Sorrento Therapeutics Inc., we are seeing an Elder Force Indicator number of -33144788.25.
The recent performance of the stock is another area that can tell traders how to proceed. SRNE is presenting an interesting case. This can be seen in the Forward P/E ratio, which currently stands at 45.64. Moreover, the company’s enterprise value has gone from $1.69B to $644.66M quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, SRNE made a profit of 6.76 million. In addition, the company has operating cash flow of -$157.93 million.
Looking at popular technical indicators, the company’s 5-day moving average is 10.60 compared to the 50-day moving average of 9.87. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. SRNE currently holds a 9-day RSI of 35.02%, while 100-day RSI stands at 54.04%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. SRNE’s 9-day MACD is -1.56 and the company’s 100-day MACD stands at 3.81.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 34.21% by insiders and 17.86% by institutions.
Over the last six months, insiders have bought 40,000 with the most recent transaction from Smith Robin L, Director, with a purchase at price 2.27 per share.
Overall, the recommended rating for SRNE is Moderate Buy. Currently, the company has 1 analysts watching the stock, and the average quarterly earnings estimate is -0.16. Quarterly revenue estimates are averaging 11.53M with the high estimate reaching 11.53M and the low at 11.53M.